APO Research

APO RESEARCH · REPORT

Drugs Produced by Fermentation Engineering

Selected research

Market Structure

Global Drugs Produced by Fermentation Engineering Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Drugs Produced by Fermentation Engineering market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Drugs Produced by Fermentation Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drugs Produced by Fermentation Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drugs Produced by Fermentation Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drugs Produced by Fermentation Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drugs Produced by Fermentation Engineering include Changchun GeneScience Pharmaceutical, Tonghua Dongbao Pharmaceutical, Sichuan Kelun Pharmaceutical, CSPC Pharmaceutical Group, Shanghai Shyndec Pharmaceutical, Shanghai Fosun Pharmaceutical, 3SBio Inc, United Laboratories International Holdings and Shandong Kexing Bioproducts, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Drugs Produced by Fermentation Engineering market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drugs Produced by Fermentation Engineering and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drugs Produced by Fermentation Engineering revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Drugs Produced by Fermentation Engineering market size, projected growth trends, production technologies, key applications, and end-use industries.

Drugs Produced by Fermentation Engineering Segment by Company

Changchun GeneScience Pharmaceutical

Tonghua Dongbao Pharmaceutical

Sichuan Kelun Pharmaceutical

CSPC Pharmaceutical Group

Shanghai Shyndec Pharmaceutical

Shanghai Fosun Pharmaceutical

3SBio Inc

United Laboratories International Holdings

Shandong Kexing Bioproducts

Joincare Pharmaceutical Group

North China Pharma

Harbin Pharmaceutical Group

Gan and Lee Pharmaceuticals

Anhui Anke Biotechnology

Drugs Produced by Fermentation Engineering Segment by Type

Monoclonal Antibodies

Antibiotic

Human Growth Hormone

Pharmaceutical Amino Acids

Insulin

Others

Drugs Produced by Fermentation Engineering Segment by Application

Hospital

Clinic

Other

Drugs Produced by Fermentation Engineering Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs Produced by Fermentation Engineering market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs Produced by Fermentation Engineering and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs Produced by Fermentation Engineering.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Drugs Produced by Fermentation Engineering in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drugs Produced by Fermentation Engineering industry.

Chapter 3: Detailed analysis of Drugs Produced by Fermentation Engineering companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs Produced by Fermentation Engineeringrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drugs Produced by Fermentation Engineering Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Monoclonal Antibodies Table 3. Key Players of Antibiotic Table 4. Key Players of Human Growth Hormone Table 3. Key Players of Pharmaceutical Amino Acids Table 4. Key Players of Insulin Table 5. Key Players of Others Table 6. Global Drugs Produced by Fermentation Engineering Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of Hospital Table 8. Key Players of Clinic Table 9. Key Players of Other Table 10. Global Drugs Produced by Fermentation Engineering Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Drugs Produced by Fermentation Engineering Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Drugs Produced by Fermentation Engineering Market Share by Region (2021-2026) Table 13. Global Drugs Produced by Fermentation Engineering Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Drugs Produced by Fermentation Engineering Market Share by Region (2027-2032) Table 15. Drugs Produced by Fermentation Engineering Industry Trends Table 16. Drugs Produced by Fermentation Engineering Industry Drivers Table 17. Drugs Produced by Fermentation Engineering Industry Opportunities and Challenges Table 18. Drugs Produced by Fermentation Engineering Industry Restraints Table 19. Global Drugs Produced by Fermentation Engineering Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Drugs Produced by Fermentation Engineering Revenue Market Share by Company (2021-2026) Table 21. Global Drugs Produced by Fermentation Engineering Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Drugs Produced by Fermentation Engineering Key Company Head Office and Area Served Table 23. Global Drugs Produced by Fermentation Engineering Company, Product Type & Application Table 24. Global Drugs Produced by Fermentation Engineering Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Drugs Produced by Fermentation Engineering by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Drugs Produced by Fermentation Engineering Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Drugs Produced by Fermentation Engineering Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Drugs Produced by Fermentation Engineering Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Drugs Produced by Fermentation Engineering Revenue Market Share by Type (2021-2026) Table 31. Global Drugs Produced by Fermentation Engineering Revenue Market Share by Type (2027-2032) Table 32. Global Drugs Produced by Fermentation Engineering Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Drugs Produced by Fermentation Engineering Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Drugs Produced by Fermentation Engineering Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Drugs Produced by Fermentation Engineering Revenue Market Share by Application (2021-2026) Table 36. Global Drugs Produced by Fermentation Engineering Revenue Market Share by Application (2027-2032) Table 37. Changchun GeneScience Pharmaceutical Company Information Table 38. Changchun GeneScience Pharmaceutical Business Overview Table 39. Changchun GeneScience Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Changchun GeneScience Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio Table 41. Changchun GeneScience Pharmaceutical Recent Development Table 42. Tonghua Dongbao Pharmaceutical Company Information Table 43. Tonghua Dongbao Pharmaceutical Business Overview Table 44. Tonghua Dongbao Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Tonghua Dongbao Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio Table 46. Tonghua Dongbao Pharmaceutical Recent Development Table 47. Sichuan Kelun Pharmaceutical Company Information Table 48. Sichuan Kelun Pharmaceutical Business Overview Table 49. Sichuan Kelun Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Sichuan Kelun Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio Table 51. Sichuan Kelun Pharmaceutical Recent Development Table 52. CSPC Pharmaceutical Group Company Information Table 53. CSPC Pharmaceutical Group Business Overview Table 54. CSPC Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. CSPC Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio Table 56. CSPC Pharmaceutical Group Recent Development Table 57. Shanghai Shyndec Pharmaceutical Company Information Table 58. Shanghai Shyndec Pharmaceutical Business Overview Table 59. Shanghai Shyndec Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Shanghai Shyndec Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio Table 61. Shanghai Shyndec Pharmaceutical Recent Development Table 62. Shanghai Fosun Pharmaceutical Company Information Table 63. Shanghai Fosun Pharmaceutical Business Overview Table 64. Shanghai Fosun Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Shanghai Fosun Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio Table 66. Shanghai Fosun Pharmaceutical Recent Development Table 67. 3SBio Inc Company Information Table 68. 3SBio Inc Business Overview Table 69. 3SBio Inc Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. 3SBio Inc Drugs Produced by Fermentation Engineering Product Portfolio Table 71. 3SBio Inc Recent Development Table 72. United Laboratories International Holdings Company Information Table 73. United Laboratories International Holdings Business Overview Table 74. United Laboratories International Holdings Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. United Laboratories International Holdings Drugs Produced by Fermentation Engineering Product Portfolio Table 76. United Laboratories International Holdings Recent Development Table 77. Shandong Kexing Bioproducts Company Information Table 78. Shandong Kexing Bioproducts Business Overview Table 79. Shandong Kexing Bioproducts Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Shandong Kexing Bioproducts Drugs Produced by Fermentation Engineering Product Portfolio Table 81. Shandong Kexing Bioproducts Recent Development Table 82. Joincare Pharmaceutical Group Company Information Table 83. Joincare Pharmaceutical Group Business Overview Table 84. Joincare Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Joincare Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio Table 86. Joincare Pharmaceutical Group Recent Development Table 87. North China Pharma Company Information Table 88. North China Pharma Business Overview Table 89. North China Pharma Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. North China Pharma Drugs Produced by Fermentation Engineering Product Portfolio Table 91. North China Pharma Recent Development Table 92. Harbin Pharmaceutical Group Company Information Table 93. Harbin Pharmaceutical Group Business Overview Table 94. Harbin Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Harbin Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio Table 96. Harbin Pharmaceutical Group Recent Development Table 97. Gan and Lee Pharmaceuticals Company Information Table 98. Gan and Lee Pharmaceuticals Business Overview Table 99. Gan and Lee Pharmaceuticals Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Gan and Lee Pharmaceuticals Drugs Produced by Fermentation Engineering Product Portfolio Table 101. Gan and Lee Pharmaceuticals Recent Development Table 102. Anhui Anke Biotechnology Company Information Table 103. Anhui Anke Biotechnology Business Overview Table 104. Anhui Anke Biotechnology Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. Anhui Anke Biotechnology Drugs Produced by Fermentation Engineering Product Portfolio Table 106. Anhui Anke Biotechnology Recent Development Table 107. North America Drugs Produced by Fermentation Engineering Market Size by Type (2021-2026) & (US$ Million) Table 108. North America Drugs Produced by Fermentation Engineering Market Size by Type (2027-2032) & (US$ Million) Table 109. North America Drugs Produced by Fermentation Engineering Market Size by Application (2021-2026) & (US$ Million) Table 110. North America Drugs Produced by Fermentation Engineering Market Size by Application (2027-2032) & (US$ Million) Table 111. North America Drugs Produced by Fermentation Engineering Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Drugs Produced by Fermentation Engineering Market Size by Country (2021-2026) Table 113. North America Drugs Produced by Fermentation Engineering Market Size by Country (2027-2032) Table 114. Europe Drugs Produced by Fermentation Engineering Market Size by Type (2021-2026) & (US$ Million) Table 115. Europe Drugs Produced by Fermentation Engineering Market Size by Type (2027-2032) & (US$ Million) Table 116. Europe Drugs Produced by Fermentation Engineering Market Size by Application (2021-2026) & (US$ Million) Table 117. Europe Drugs Produced by Fermentation Engineering Market Size by Application (2027-2032) & (US$ Million) Table 118. Europe Drugs Produced by Fermentation Engineering Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Europe Drugs Produced by Fermentation Engineering Market Size by Country (2021-2026) Table 120. Europe Drugs Produced by Fermentation Engineering Market Size by Country (2027-2032) Table 121. China Drugs Produced by Fermentation Engineering Market Size by Type (2021-2026) & (US$ Million) Table 122. China Drugs Produced by Fermentation Engineering Market Size by Type (2027-2032) & (US$ Million) Table 123. China Drugs Produced by Fermentation Engineering Market Size by Application (2021-2026) & (US$ Million) Table 124. China Drugs Produced by Fermentation Engineering Market Size by Application (2027-2032) & (US$ Million) Table 125. Asia Drugs Produced by Fermentation Engineering Market Size by Type (2021-2026) & (US$ Million) Table 126. Asia Drugs Produced by Fermentation Engineering Market Size by Type (2027-2032) & (US$ Million) Table 127. Asia Drugs Produced by Fermentation Engineering Market Size by Application (2021-2026) & (US$ Million) Table 128. Asia Drugs Produced by Fermentation Engineering Market Size by Application (2027-2032) & (US$ Million) Table 129. Asia Drugs Produced by Fermentation Engineering Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Asia Drugs Produced by Fermentation Engineering Market Size by Country (2021-2026) Table 131. Asia Drugs Produced by Fermentation Engineering Market Size by Country (2027-2032) Table 132. South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Type (2021-2026) & (US$ Million) Table 133. South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Type (2027-2032) & (US$ Million) Table 134. South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Application (2021-2026) & (US$ Million) Table 135. South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Application (2027-2032) & (US$ Million) Table 136. South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Country (2021-2026) Table 138. South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Country (2027-2032) Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Drugs Produced by Fermentation Engineering Product Image Figure 2. Global Drugs Produced by Fermentation Engineering Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Drugs Produced by Fermentation Engineering Market Share by Type: 2025 VS 2032 Figure 4. Monoclonal Antibodies Image Figure 5. Antibiotic Image Figure 6. Human Growth Hormone Image Figure 7. Pharmaceutical Amino Acids Image Figure 8. Insulin Image Figure 9. Others Image Figure 10. Global Drugs Produced by Fermentation Engineering Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global Drugs Produced by Fermentation Engineering Market Share by Application: 2025 VS 2032 Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Other Image Figure 15. Global Drugs Produced by Fermentation Engineering Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 17. Global Drugs Produced by Fermentation Engineering Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Drugs Produced by Fermentation Engineering Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Drugs Produced by Fermentation Engineering Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Drugs Produced by Fermentation Engineering Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Drugs Produced by Fermentation Engineering Revenue Market Share by Type (2021-2032) Figure 24. Global Drugs Produced by Fermentation Engineering Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Drugs Produced by Fermentation Engineering Revenue Market Share by Application (2021-2032) Figure 26. North America Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 27. North America Drugs Produced by Fermentation Engineering Market Share by Type (2021-2032) Figure 28. North America Drugs Produced by Fermentation Engineering Market Share by Application (2021-2032) Figure 29. North America Drugs Produced by Fermentation Engineering Market Share by Country (2021-2032) Figure 30. United States Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 31. Canada Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 33. Europe Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 34. Europe Drugs Produced by Fermentation Engineering Market Share by Type (2021-2032) Figure 35. Europe Drugs Produced by Fermentation Engineering Market Share by Application (2021-2032) Figure 36. Europe Drugs Produced by Fermentation Engineering Market Share by Country (2021-2032) Figure 37. Germany Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 38. France Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 40. Italy Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 41. Russia Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 43. China Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 44. China Drugs Produced by Fermentation Engineering Market Share by Type (2021-2032) Figure 45. China Drugs Produced by Fermentation Engineering Market Share by Application (2021-2032) Figure 46. Asia Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 47. Asia Drugs Produced by Fermentation Engineering Market Share by Type (2021-2032) Figure 48. Asia Drugs Produced by Fermentation Engineering Market Share by Application (2021-2032) Figure 49. Asia Drugs Produced by Fermentation Engineering Market Share by Country (2021-2032) Figure 50. Japan Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 54. India Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 55. Australia Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Share by Country (2021-2032) Figure 60. Brazil Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 65. UAE Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 67. Chile Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibodies
  • Antibiotic
  • Human Growth Hormone
  • Pharmaceutical Amino Acids
  • Insulin
  • Others
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Changchun GeneScience Pharmaceutical
  • Tonghua Dongbao Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • CSPC Pharmaceutical Group
  • Shanghai Shyndec Pharmaceutical
  • Shanghai Fosun Pharmaceutical
  • 3SBio Inc
  • United Laboratories International Holdings
  • Shandong Kexing Bioproducts
  • Joincare Pharmaceutical Group
  • North China Pharma
  • Harbin Pharmaceutical Group
  • Gan and Lee Pharmaceuticals
  • Anhui Anke Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Drugs Produced by Fermentation Engineering Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Monoclonal Antibodies
  5. 1.2.3 Antibiotic
  6. 1.2.4 Human Growth Hormone
  7. 1.2.5 Pharmaceutical Amino Acids
  8. 1.2.6 Insulin
  9. 1.2.7 Others
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global Drugs Produced by Fermentation Engineering Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 Hospital
  13. 1.3.3 Clinic
  14. 1.3.4 Other
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Drugs Produced by Fermentation Engineering Growth Trends by Region
  17. 1.5.1 Global Drugs Produced by Fermentation Engineering Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Drugs Produced by Fermentation Engineering Market Size by Region (2021-2026)
  19. 1.5.3 Drugs Produced by Fermentation Engineering Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Drugs Produced by Fermentation Engineering Market Dynamics
  1. 2.1 Drugs Produced by Fermentation Engineering Industry Trends
  2. 2.2 Drugs Produced by Fermentation Engineering Industry Drivers
  3. 2.3 Drugs Produced by Fermentation Engineering Industry Opportunities and Challenges
  4. 2.4 Drugs Produced by Fermentation Engineering Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Drugs Produced by Fermentation Engineering Revenue by Company (2021-2026)
  2. 3.2 Global Drugs Produced by Fermentation Engineering Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Drugs Produced by Fermentation Engineering Key Company Head office and Area Served
  4. 3.4 Global Drugs Produced by Fermentation Engineering Company, Product Type & Application
  5. 3.5 Global Drugs Produced by Fermentation Engineering Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Drugs Produced by Fermentation Engineering Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Drugs Produced by Fermentation Engineering Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Drugs Produced by Fermentation Engineering Tier 1, Tier 2, and Tier 3
4 Drugs Produced by Fermentation Engineering Market by Type
  1. 4.1 Global Drugs Produced by Fermentation Engineering Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Drugs Produced by Fermentation Engineering Market Size by Type (2021-2032)
  3. 4.3 Global Drugs Produced by Fermentation Engineering Market Size Share by Type (2021-2032)
5 Drugs Produced by Fermentation Engineering Market by Application
  1. 5.1 Global Drugs Produced by Fermentation Engineering Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Drugs Produced by Fermentation Engineering Market Size by Application (2021-2032)
  3. 5.3 Global Drugs Produced by Fermentation Engineering Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Changchun GeneScience Pharmaceutical
  2. 6.1.1 Changchun GeneScience Pharmaceutical Company Information
  3. 6.1.2 Changchun GeneScience Pharmaceutical Business Overview
  4. 6.1.3 Changchun GeneScience Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Changchun GeneScience Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio
  6. 6.1.5 Changchun GeneScience Pharmaceutical Recent Developments
  7. 6.2 Tonghua Dongbao Pharmaceutical
  8. 6.2.1 Tonghua Dongbao Pharmaceutical Company Information
  9. 6.2.2 Tonghua Dongbao Pharmaceutical Business Overview
  10. 6.2.3 Tonghua Dongbao Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Tonghua Dongbao Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio
  12. 6.2.5 Tonghua Dongbao Pharmaceutical Recent Developments
  13. 6.3 Sichuan Kelun Pharmaceutical
  14. 6.3.1 Sichuan Kelun Pharmaceutical Company Information
  15. 6.3.2 Sichuan Kelun Pharmaceutical Business Overview
  16. 6.3.3 Sichuan Kelun Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Sichuan Kelun Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio
  18. 6.3.5 Sichuan Kelun Pharmaceutical Recent Developments
  19. 6.4 CSPC Pharmaceutical Group
  20. 6.4.1 CSPC Pharmaceutical Group Company Information
  21. 6.4.2 CSPC Pharmaceutical Group Business Overview
  22. 6.4.3 CSPC Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 CSPC Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio
  24. 6.4.5 CSPC Pharmaceutical Group Recent Developments
  25. 6.5 Shanghai Shyndec Pharmaceutical
  26. 6.5.1 Shanghai Shyndec Pharmaceutical Company Information
  27. 6.5.2 Shanghai Shyndec Pharmaceutical Business Overview
  28. 6.5.3 Shanghai Shyndec Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Shanghai Shyndec Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio
  30. 6.5.5 Shanghai Shyndec Pharmaceutical Recent Developments
  31. 6.6 Shanghai Fosun Pharmaceutical
  32. 6.6.1 Shanghai Fosun Pharmaceutical Company Information
  33. 6.6.2 Shanghai Fosun Pharmaceutical Business Overview
  34. 6.6.3 Shanghai Fosun Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Shanghai Fosun Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio
  36. 6.6.5 Shanghai Fosun Pharmaceutical Recent Developments
  37. 6.7 3SBio Inc
  38. 6.7.1 3SBio Inc Company Information
  39. 6.7.2 3SBio Inc Business Overview
  40. 6.7.3 3SBio Inc Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 3SBio Inc Drugs Produced by Fermentation Engineering Product Portfolio
  42. 6.7.5 3SBio Inc Recent Developments
  43. 6.8 United Laboratories International Holdings
  44. 6.8.1 United Laboratories International Holdings Company Information
  45. 6.8.2 United Laboratories International Holdings Business Overview
  46. 6.8.3 United Laboratories International Holdings Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 United Laboratories International Holdings Drugs Produced by Fermentation Engineering Product Portfolio
  48. 6.8.5 United Laboratories International Holdings Recent Developments
  49. 6.9 Shandong Kexing Bioproducts
  50. 6.9.1 Shandong Kexing Bioproducts Company Information
  51. 6.9.2 Shandong Kexing Bioproducts Business Overview
  52. 6.9.3 Shandong Kexing Bioproducts Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Shandong Kexing Bioproducts Drugs Produced by Fermentation Engineering Product Portfolio
  54. 6.9.5 Shandong Kexing Bioproducts Recent Developments
  55. 6.10 Joincare Pharmaceutical Group
  56. 6.10.1 Joincare Pharmaceutical Group Company Information
  57. 6.10.2 Joincare Pharmaceutical Group Business Overview
  58. 6.10.3 Joincare Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Joincare Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio
  60. 6.10.5 Joincare Pharmaceutical Group Recent Developments
  61. 6.11 North China Pharma
  62. 6.11.1 North China Pharma Company Information
  63. 6.11.2 North China Pharma Business Overview
  64. 6.11.3 North China Pharma Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 North China Pharma Drugs Produced by Fermentation Engineering Product Portfolio
  66. 6.11.5 North China Pharma Recent Developments
  67. 6.12 Harbin Pharmaceutical Group
  68. 6.12.1 Harbin Pharmaceutical Group Company Information
  69. 6.12.2 Harbin Pharmaceutical Group Business Overview
  70. 6.12.3 Harbin Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Harbin Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio
  72. 6.12.5 Harbin Pharmaceutical Group Recent Developments
  73. 6.13 Gan and Lee Pharmaceuticals
  74. 6.13.1 Gan and Lee Pharmaceuticals Company Information
  75. 6.13.2 Gan and Lee Pharmaceuticals Business Overview
  76. 6.13.3 Gan and Lee Pharmaceuticals Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Gan and Lee Pharmaceuticals Drugs Produced by Fermentation Engineering Product Portfolio
  78. 6.13.5 Gan and Lee Pharmaceuticals Recent Developments
  79. 6.14 Anhui Anke Biotechnology
  80. 6.14.1 Anhui Anke Biotechnology Company Information
  81. 6.14.2 Anhui Anke Biotechnology Business Overview
  82. 6.14.3 Anhui Anke Biotechnology Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Anhui Anke Biotechnology Drugs Produced by Fermentation Engineering Product Portfolio
  84. 6.14.5 Anhui Anke Biotechnology Recent Developments
7 North America
  1. 7.1 North America Drugs Produced by Fermentation Engineering Market Size (2021-2032)
  2. 7.2 North America Drugs Produced by Fermentation Engineering Market Size by Type
  3. 7.2.1 North America Drugs Produced by Fermentation Engineering Market Size by Type (2021-2026)
  4. 7.2.2 North America Drugs Produced by Fermentation Engineering Market Size by Type (2027-2032)
  5. 7.2.3 North America Drugs Produced by Fermentation Engineering Market Share by Type (2021-2032)
  6. 7.3 North America Drugs Produced by Fermentation Engineering Market Size by Application
  7. 7.3.1 North America Drugs Produced by Fermentation Engineering Market Size by Application (2021-2026)
  8. 7.3.2 North America Drugs Produced by Fermentation Engineering Market Size by Application (2027-2032)
  9. 7.3.3 North America Drugs Produced by Fermentation Engineering Market Share by Application (2021-2032)
  10. 7.4 North America Drugs Produced by Fermentation Engineering Market Size by Country
  11. 7.4.1 North America Drugs Produced by Fermentation Engineering Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Drugs Produced by Fermentation Engineering Market Size by Country (2021-2026)
  13. 7.4.3 North America Drugs Produced by Fermentation Engineering Market Size by Country (2027-2032)
  14. 7.4.4 North America Drugs Produced by Fermentation Engineering Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Drugs Produced by Fermentation Engineering Market Size (2021-2032)
  2. 8.2 Europe Drugs Produced by Fermentation Engineering Market Size by Type
  3. 8.2.1 Europe Drugs Produced by Fermentation Engineering Market Size by Type (2021-2026)
  4. 8.2.2 Europe Drugs Produced by Fermentation Engineering Market Size by Type (2027-2032)
  5. 8.2.3 Europe Drugs Produced by Fermentation Engineering Market Share by Type (2021-2032)
  6. 8.3 Europe Drugs Produced by Fermentation Engineering Market Size by Application
  7. 8.3.1 Europe Drugs Produced by Fermentation Engineering Market Size by Application (2021-2026)
  8. 8.3.2 Europe Drugs Produced by Fermentation Engineering Market Size by Application (2027-2032)
  9. 8.3.3 Europe Drugs Produced by Fermentation Engineering Market Share by Application (2021-2032)
  10. 8.4 Europe Drugs Produced by Fermentation Engineering Market Size by Country
  11. 8.4.1 Europe Drugs Produced by Fermentation Engineering Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Drugs Produced by Fermentation Engineering Market Size by Country (2021-2026)
  13. 8.4.3 Europe Drugs Produced by Fermentation Engineering Market Size by Country (2027-2032)
  14. 8.4.4 Europe Drugs Produced by Fermentation Engineering Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Drugs Produced by Fermentation Engineering Market Size (2021-2032)
  2. 9.2 China Drugs Produced by Fermentation Engineering Market Size by Type
  3. 9.2.1 China Drugs Produced by Fermentation Engineering Market Size by Type (2021-2026)
  4. 9.2.2 China Drugs Produced by Fermentation Engineering Market Size by Type (2027-2032)
  5. 9.2.3 China Drugs Produced by Fermentation Engineering Market Share by Type (2021-2032)
  6. 9.3 China Drugs Produced by Fermentation Engineering Market Size by Application
  7. 9.3.1 China Drugs Produced by Fermentation Engineering Market Size by Application (2021-2026)
  8. 9.3.2 China Drugs Produced by Fermentation Engineering Market Size by Application (2027-2032)
  9. 9.3.3 China Drugs Produced by Fermentation Engineering Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Drugs Produced by Fermentation Engineering Market Size (2021-2032)
  2. 10.2 Asia Drugs Produced by Fermentation Engineering Market Size by Type
  3. 10.2.1 Asia Drugs Produced by Fermentation Engineering Market Size by Type (2021-2026)
  4. 10.2.2 Asia Drugs Produced by Fermentation Engineering Market Size by Type (2027-2032)
  5. 10.2.3 Asia Drugs Produced by Fermentation Engineering Market Share by Type (2021-2032)
  6. 10.3 Asia Drugs Produced by Fermentation Engineering Market Size by Application
  7. 10.3.1 Asia Drugs Produced by Fermentation Engineering Market Size by Application (2021-2026)
  8. 10.3.2 Asia Drugs Produced by Fermentation Engineering Market Size by Application (2027-2032)
  9. 10.3.3 Asia Drugs Produced by Fermentation Engineering Market Share by Application (2021-2032)
  10. 10.4 Asia Drugs Produced by Fermentation Engineering Market Size by Country
  11. 10.4.1 Asia Drugs Produced by Fermentation Engineering Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Drugs Produced by Fermentation Engineering Market Size by Country (2021-2026)
  13. 10.4.3 Asia Drugs Produced by Fermentation Engineering Market Size by Country (2027-2032)
  14. 10.4.4 Asia Drugs Produced by Fermentation Engineering Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Drugs Produced by Fermentation Engineering Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research